Allergan (AGN) EV/EBITDA US GAAP (year values) |
|||||||||
| 2015 | 2016 | 2017 | 2018 | 2019 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | 16.4 | 4.78 | -33.6 | 84.4 | 46.3 | 29.8 | ||
| Changes by years, y/y, % | -60% | -71% | -802% | -352% | -45% | +2.7% | |||
Allergan. EV/EBITDA
Allergan. EV/EBITDA, changes, %
Allergan (AGN) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2019Q1 | 2019Q2 | 2019Q3 | 2019Q4 | 2020Q1 | LTM ? | |||
| EV/EBITDA | ? | -66.6 | -31.9 | -21.7 | 46.2 | 27.9 | 29.8 | |
| Changes by years, y/y, % | -309% | -230% | -319% | -44% | -142% | |||
| Changes by quarters, q/q, % | -181% | -52% | -32% | -313% | -40% | |||